MFDS — authorised 7 August 1973
- Marketing authorisation holder: IMPAX LABS
- Status: likely_approved
🇰🇷 Pyrilamine in South Korea
MFDS authorised Pyrilamine on 7 August 1973
Marketing authorisation
Pyrilamine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Pyrilamine approved in South Korea?
Yes. MFDS authorised it on 7 August 1973.
Who is the marketing authorisation holder for Pyrilamine in South Korea?
IMPAX LABS holds the South Korean marketing authorisation.